Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Peter Lin MD, CCFP

Peter Lin MD, CCFP

Director, Primary Care Initiatives, Canadian Heart Research Centre, North York, Ontario

Dr. Peter Lin, a primary care physician, is the Director of Primary Care Initiatives at the Canadian Heart Research Centre and has two busy family medicine practices in Toronto. For 7 years, he served as the medical director at the University of Toronto Scarborough Health & Wellness Centre. In 2011, he received a teaching award from the College of Family Physicians of Canada.

Dr. Lin has worked with KDIGO (Kidney Disease│Improving Global Outcomes) in an effort to help enhance care for patients with chronic kidney disease. He has been a contributing author to the Canadian Diabetes Guidelines and has served on the editorial board of Pri-Med Institute, which provides education for physicians.

Dr. Lin maintains an active lecture schedule, reflecting his varied medical interests, continuing his focus on bridging the chasm between research and clinical practice.

Disclosures

  • Consultant (continuing medical education programs): AstraZeneca; Boehringer Ingelheim; Bayer; Eli Lilly; Amgen; Janssen; Merck; Pfizer; Sanofi; Abbott; HLS Therapeutics

Recent Contributions to PracticeUpdate:

  1. Use of Aspirin to Reduce Risk of Initial Vascular Events in Patients at Moderate Risk of Cardiovascular Disease
  2. Aspirin Use Prevents Serious Vascular Events, Increases Major Bleeding Events in Diabetes
  3. CV Risk Factors at Recommended Levels Are Associated With Increased Cerebral Vessel Density and Caliber
  4. Good Cardiovascular Health May Lower the Risk of Cognitive Decline and Dementia in Older Adults
  5. Fixed Low-Dose Triple-Combination Antihypertensive Medication Superior to Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension
  6. SGLT2 Inhibitors Associated With Lower-Extremity Amputation Among Patients With Type 2 Diabetes
  7. Aspirin Plus Clopidogrel Prevents Cardiovascular Events in Patients at High Risk
  8. Escitalopram vs Placebo Treatment for Depression Improves Long-Term Cardiac Outcomes in Patients With Acute Coronary Syndrome
  9. Effects of Aspirin on Risks of Vascular Events and Cancer According to Body Weight and Dose
  10. Asthma and Poor Asthma Control Associated With Atrial Fibrillation Risk

Most Read This Week

Recently Updated